冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300238 冠昊生物

已收盘 12-17 15:00:00

{"stockData":{"symbol":"300238","market":"SZ","secType":"STK","nameCN":"冠昊生物","latestPrice":13.98,"timestamp":1765955022000,"preClose":13.84,"halted":0,"volume":3432100,"delay":0,"changeRate":0.0101,"floatShares":265000000,"shares":265000000,"eps":0.0992,"marketStatus":"已收盘","change":0.14,"latestTime":"12-17 15:00:00","open":13.8,"high":13.99,"low":13.69,"amount":47495500,"amplitude":0.0217,"askPrice":13.99,"askSize":500,"bidPrice":13.98,"bidSize":24,"shortable":0,"etf":0,"ttmEps":0.0992,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.84,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":15.22,"lowLimit":12.46,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":265155701,"isCdr":false,"pbRate":6.41,"roa":"--","peRate":140.927419,"roe":"4.79%","epsLYR":0.1,"committee":-0.549953,"marketValue":3707000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":3707000000},"requestUrl":"/m/hq/s/300238/tweets","defaultTab":"tweets","newsList":[{"id":"2591463612","title":"冠昊生物(300238)12月10日股东户数2.9万户，较上期减少2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591463612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591463612?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:47","pubTimestamp":1765792042,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2025年12月10日公司股东户数为2.9万户，较11月28日减少712.0户，减幅为2.4%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至12月10日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年11月28日至2025年12月10日，冠昊生物区间跌幅为5.65%，在此期间股东户数减少712.0户，减幅为2.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300238","BK0086","BK0251","BK0077"],"gpt_icon":0},{"id":"2588702301","title":"冠昊生物：截至2025年11月28日股东总户数为29672","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702301","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588702301?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:48","pubTimestamp":1764636492,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至11月底公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月28日，公司股东总户数为29672。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0251","BK0046","BK0077","BK0042","BK0086"],"gpt_icon":0},{"id":"2586623299","title":"冠昊生物：生物人工肝项目已完成临床前研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2586623299","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586623299?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:48","pubTimestamp":1764146892,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物11月26日在投资者关系平台上答复投资者关心的问题。公司相关项目研究正积极有序推进中，其中生物人工肝项目目前已完成临床前研究，正积极推动临床转化，后续公司将根据项目具体进展情况，严格按照监管规定及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600023516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","BK0086","BK0046","300238","BK0042"],"gpt_icon":0},{"id":"2585454009","title":"冠昊生物：截止2025年11月20日股东总户数为29645","url":"https://stock-news.laohu8.com/highlight/detail?id=2585454009","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585454009?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:23","pubTimestamp":1763972604,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到11月20日的最新股东人数是多少，谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月20日，公司股东总户数为29645。感谢您的关注与支持！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251124/31819338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0077","300238","BK0042","BK0086","BK0046"],"gpt_icon":0},{"id":"2583351821","title":"股市必读：冠昊生物(300238)股东户数2.96万户，较上期增加4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583351821","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583351821?lang=zh_cn&edition=full","pubTime":"2025-11-14 01:52","pubTimestamp":1763056336,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，冠昊生物报收于16.93元，下跌1.11%，换手率7.99%，成交量21.19万手，成交额3.56亿元。当日关注点来自交易信息汇总：11月13日主力资金净流出1878.86万元，散户资金净流入1688.01万元。股本股东变化股东户数变动近日冠昊生物披露，截至2025年11月10日公司股东户数为2.96万户，较10月31日增加1194.0户，增幅为4.2%。户均持股数量由上期的9328.0股减少至8952.0股，户均持股市值为14.56万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300238","BK0086","BK0251","BK0042","BK0046"],"gpt_icon":0},{"id":"2583858086","title":"冠昊生物：截止2025年11月10日股东总户数为29620","url":"https://stock-news.laohu8.com/highlight/detail?id=2583858086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583858086?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:42","pubTimestamp":1762994534,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，截止到2025年11月10日公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年11月10日，公司股东总户数为29620。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0251","BK0046","BK0077","BK0042","BK0086"],"gpt_icon":0},{"id":"2580273140","title":"冠昊生物：截至2025年10月31日股东总户数为28426","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273140?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:09","pubTimestamp":1762218552,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截至10月底公司的股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年10月31日，公司股东总户数为28426。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0251","BK0042","BK0077","300238","BK0046"],"gpt_icon":0},{"id":"2578517931","title":"冠昊生物(300238.SZ)发布前三季度业绩，归母净利润2671.85万元，下降4.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578517931","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578517931?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:51","pubTimestamp":1761645110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，冠昊生物(300238.SZ)发布2025年三季度报告，该公司前三季度营业收入为2.93亿元，同比增长5.52%。归属于上市公司股东的净利润为2671.85万元，同比减少4.02%。归属于上市公司股东的扣除非经常性损益的净利润为2582.06万元，同比增长27.60%。基本每股收益为0.1元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300238"],"gpt_icon":0},{"id":"2577315980","title":"股市必读：冠昊生物(300238)股东户数2.85万户，较上期增加1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577315980","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577315980?lang=zh_cn&edition=full","pubTime":"2025-10-23 03:46","pubTimestamp":1761162371,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，冠昊生物报收于15.75元，上涨0.13%，换手率1.41%，成交量3.74万手，成交额5899.51万元。当日关注点来自交易信息汇总：10月22日主力资金净流入329.85万元，呈现资金主动介入迹象。股本股东变化股东户数变动近日冠昊生物披露，截至2025年10月20日公司股东户数为2.85万户，较10月10日增加332.0户，增幅为1.18%。户均持股数量由上期的9405.0股减少至9296.0股，户均持股市值为14.54万元。董秘最新回复投资者： 请问截止2025年10月20日，公司股东人数多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300003346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","300238","BK0042","BK0077","BK0046","BK0251"],"gpt_icon":0},{"id":"2577356939","title":"冠昊生物：截止2025年10月20日股东总户数为28525","url":"https://stock-news.laohu8.com/highlight/detail?id=2577356939","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577356939?lang=zh_cn&edition=full","pubTime":"2025-10-22 16:06","pubTimestamp":1761120386,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年10月20日，公司股东人数多少？冠昊生物回复：尊敬的投资者您好！截止2025年10月20日，公司股东总户数为28525。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200024198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300238","BK0086","BK0251","BK0077"],"gpt_icon":0},{"id":"2576300581","title":"股市必读：冠昊生物（300238）10月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576300581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576300581?lang=zh_cn&edition=full","pubTime":"2025-10-20 04:00","pubTimestamp":1760904045,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，冠昊生物报收于15.33元，下跌2.23%，换手率1.53%，成交量4.04万手，成交额6266.35万元。董秘最新回复投资者： 诺和诺德和武田制药都相继退出细胞疗法的研究，并关闭相关部门，据说是耗费时间和大量资本，但回报很难。当日关注点来自交易信息汇总：10月17日主力资金净流出211.41万元，游资资金净流入199.83万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0077","BK0046","BK0086","BK0251"],"gpt_icon":0},{"id":"2576208787","title":"冠昊生物：核心业务包括材料、药业、细胞三大板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2576208787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576208787?lang=zh_cn&edition=full","pubTime":"2025-10-17 16:45","pubTimestamp":1760690724,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物10月17日在投资者关系平台上答复投资者关心的问题。公司核心业务包括材料、药业、细胞三大业务板块，其中细胞领域主要有细胞储存、细胞软骨治疗等等，详细情况请关注公司披露的定期报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700025840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","300238","BK0042","BK0086","BK0046"],"gpt_icon":0},{"id":"2575728704","title":"股市必读：冠昊生物(300238)股东户数2.82万户，较上期减少0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575728704","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575728704?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:50","pubTimestamp":1760385021,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，冠昊生物报收于15.16元，下跌0.26%，换手率1.58%，成交量4.18万手，成交额6243.48万元。股本股东变化股东户数变动近日冠昊生物披露，截至2025年10月10日公司股东户数为2.82万户，较9月30日减少122.0户，减幅为0.43%。户均持股数量由上期的9364.0股增加至9405.0股，户均持股市值为14.3万元。投资者： 尊敬的董秘大大，请问截止到10月10日的最新股东人数是多少，谢谢！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400029773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0251","BK0077","BK0046","300238"],"gpt_icon":0},{"id":"2575475370","title":"冠昊生物：截止2025年10月10日股东总户数为28193","url":"https://stock-news.laohu8.com/highlight/detail?id=2575475370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575475370?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:27","pubTimestamp":1760344036,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)10月13日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问贵公司最新的股东人数多少？谢谢冠昊生物回复：尊敬的投资者您好！截止2025年10月10日，公司股东总户数为28193。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300015876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300238","BK0251","BK0046","BK0086"],"gpt_icon":0},{"id":"2574813104","title":"冠昊生物：截止2025年9月30日股东总户数为28315","url":"https://stock-news.laohu8.com/highlight/detail?id=2574813104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574813104?lang=zh_cn&edition=full","pubTime":"2025-10-09 16:36","pubTimestamp":1759998983,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年9月30日公司股东人数有多少？谢谢冠昊生物回复：尊敬的投资者您好！截止2025年9月30日，公司股东总户数为28315。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900020758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0046","BK0077","BK0251","300238"],"gpt_icon":0},{"id":"2574288974","title":"股市必读：冠昊生物（300238）9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2574288974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574288974?lang=zh_cn&edition=full","pubTime":"2025-10-09 03:48","pubTimestamp":1759952896,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，冠昊生物报收于15.36元，上涨1.32%，换手率1.41%，成交量3.74万手，成交额5717.83万元。公司研发项目的有关情况请关注公司披露的定期报告。交易信息汇总资金流向9月30日主力资金净流出446.45万元，占总成交额7.81%；游资资金净流出370.94万元，占总成交额6.49%；散户资金净流入817.38万元，占总成交额14.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900001073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","300238","BK0042","BK0086","BK0251"],"gpt_icon":0},{"id":"2569204249","title":"冠昊生物：截止2025年9月19日股东总户数为28116","url":"https://stock-news.laohu8.com/highlight/detail?id=2569204249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569204249?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:09","pubTimestamp":1758528551,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问贵公司最新股东人数是多少？谢谢冠昊生物回复：尊敬的投资者您好！截止2025年9月19日，公司股东总户数为28116。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200019469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0086","BK0046","BK0077","300238","BK0042"],"gpt_icon":0},{"id":"2567015745","title":"股市必读：冠昊生物(300238)股东户数2.82万户，较上期减少2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567015745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567015745?lang=zh_cn&edition=full","pubTime":"2025-09-15 03:56","pubTimestamp":1757879773,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，冠昊生物报收于16.43元，上涨1.55%，换手率1.87%，成交量4.96万手，成交额8033.91万元。来自股本股东变化：截至9月10日股东户数环比减少2.37%，户均持股数量上升至9408.0股，筹码集中度提升。股本股东变化股东户数变动截至2025年9月10日，冠昊生物股东户数为2.82万户，较8月29日减少685.0户，减幅为2.37%。董秘最新回复投资者： 尊敬的董秘大大，请问截止到9月10日的最新股东人数是多少，谢谢！截止2025年9月10日，公司股东总户数为28184。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500001208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0251","BK0077","BK0042","300238"],"gpt_icon":0},{"id":"2566921646","title":"冠昊生物：截止9月10日股东总户数为28184","url":"https://stock-news.laohu8.com/highlight/detail?id=2566921646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566921646?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:03","pubTimestamp":1757664200,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)09月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘大大，请问截止到9月10日的最新股东人数是多少，谢谢！冠昊生物回复：尊敬的投资者您好！截止2025年9月10日，公司股东总户数为28184。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200023708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0251","BK0046","BK0077","BK0042","BK0086"],"gpt_icon":0},{"id":"2566898475","title":"股市必读：冠昊生物（300238）9月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2566898475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566898475?lang=zh_cn&edition=full","pubTime":"2025-09-11 04:04","pubTimestamp":1757534657,"startTime":"0","endTime":"0","summary":"截至2025年9月10日收盘，冠昊生物报收于16.1元，下跌0.68%，换手率1.13%，成交量3.0万手，成交额4860.73万元。董秘最新回复投资者： 公司近几年营收、利润率都表现的不尽如人意，下一步有什么计划吗？2025年5月，公司子公司北昊研究院自主研发的外泌体成功获得美国FDA 药物主文件 II型原料药备案资格。当日关注点来自交易信息汇总：9月10日主力资金净流出182.56万元，散户资金净流入586.78万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100003690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0077","BK0046","BK0086","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765994659076,"stockEarnings":[{"period":"1week","weight":-0.0271},{"period":"1month","weight":-0.1512},{"period":"3month","weight":-0.1279},{"period":"6month","weight":-0.0723},{"period":"1year","weight":0.0631},{"period":"ytd","weight":0.1611}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"冠昊生物科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"28960人(较上一季度减少2.40%)","perCapita":"9155股","listingDate":"2011-07-06","address":"广东省广州市黄埔区玉岩路12号","registeredCapital":"26515万元","survey":"　　冠昊生物科技股份有限公司的主营业务是再生医学材料及再生型医用植入器械研发、生产及销售。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、欣比克本维莫德乳膏。","listedPrice":18.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冠昊生物,300238,冠昊生物股票,冠昊生物股票老虎,冠昊生物股票老虎国际,冠昊生物行情,冠昊生物股票行情,冠昊生物股价,冠昊生物股市,冠昊生物股票价格,冠昊生物股票交易,冠昊生物股票购买,冠昊生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}